A) Biocompatibility B) Inflammability C) Toxicity D) Corrosiveness
A) To induce inflammation B) To block cell growth C) To provide a structure for cells to grow and organize D) To prevent regeneration
A) Chemical stability B) Fatigue resistance C) Thermal conductivity D) Biodegradability
A) Biocompatibility B) High cost C) Corrosion D) Heavy weight
A) Reduce mechanical strength B) Decrease biocompatibility C) Increase toxicity D) Enhanced surface interactions and properties
A) Silicone rubber B) PMMA C) Polyethylene D) Hydroxyapatite
A) Red blood cells B) Keratinocytes C) Fibroblasts D) Macrophages
A) To prevent infections B) To promote inflammation C) To increase toxicity D) To accelerate degradation
A) Astrophysics B) Quantum mechanics C) Marine biology D) Biomaterials science or biomaterials engineering
A) There is no difference between them B) Biological materials are always synthetic C) Biomaterials cannot be used in medical applications D) Biomaterials are engineered, while biological materials are naturally produced
A) Only natural fibers B) Metallic components, polymers, ceramics, or composite materials C) Exclusively organic compounds D) Pure water-based solutions
A) Through random trial and error methods B) Exclusively through animal testing C) Using only historical data without new testing D) By computational routines predicting molecular effects based on limited in vitro experimentation
A) The random distribution of particles in a solution. B) A process requiring mechanical manipulation to form structures. C) The spontaneous aggregation of particles without external forces. D) An assembly method that uses magnetic fields.
A) The chemical composition of particles. B) The spatial scale of the unit cell (lattice parameter). C) The external forces applied to the system. D) The temperature at which assembly occurs.
A) Self-organization. B) Random particle distribution. C) External guidance and control. D) Chemical bonding between particles.
A) 60 nm. B) 1.5 nm. C) 3 nm. D) 70 to 100 nm.
A) 80/20. B) 70/30. C) 50/50. D) About 60/40.
A) Within the mineral phase only. B) On the surface of tropocollagen molecules. C) Randomly throughout the matrix. D) At the gaps between collagen fibrils.
A) 1 μm diameter rods. B) 60 nm diameter canals. C) "Bricks" with dimensions of 0.5. D) 20 to 30 nm layers.
A) Hydroxyapatite. B) Collagen. C) Calcium carbonate. D) Chitin.
A) A helical pattern. B) An amorphous structure. C) A cubic pattern. D) A random distribution.
A) 60 nm. B) 70 to 100 nm. C) 20 to 30 nm. D) 1 μm.
A) ISO 27001 B) ISO 14001 C) ISO 10993 D) ISO 9001
A) Nucleotides B) Sugars C) Amino acids D) Fatty acids
A) Dental filling material B) Artificial skin scaffold C) Heart valve coating D) Bone graft substitute
A) Pyrolytic carbon B) Polyethylene terephthalate C) Calcium sulfate D) Stainless steel
A) Synthetic polymers B) Animal skin C) Metal wires D) Plant fibers
A) 20 different configurations B) 10 different configurations C) 14 different configurations D) 5 different configurations
A) Nylon B) Dacron C) Kevlar D) Spandex
A) Inflammatory reaction B) Foreign body response (FBR) C) Healing process D) Immune response
A) Sub atomic level B) Ultra-structure level C) Microstructure level D) Molecular level
A) 60% B) 49% C) 75% D) 25%
A) Mechanically strong B) Chemically reactive C) Non-biodegradable D) Electrically conductive
A) 3 nm. B) 60 nm. C) 20 to 30 nm. D) 1 μm.
A) 70 to 100 nm. B) 3 mm. C) 1.5 nm. D) Approximately 60 nm.
A) Biofabrication B) Biomimetics C) Biodegradation D) Biocompatibility
A) Later 1960s B) 2000s C) Early 1950s D) 1980s
A) Drug delivery B) Bone strengthening C) Tissue growth stimulation D) Wound closure
A) Acute phase B) Healing phase C) Resolution phase D) Chronic phase
A) Biocompatible B) Brittle C) Toxic D) Non-degradable
A) Elasticity B) Shape C) Alignment D) Size
A) Silica B) Polyetheretherketone (PEEK) C) Liposomes D) Polymers
A) DNA B) Starch C) Proteins D) Cellulose
A) Eosinophils B) Macrophages C) Neutrophils D) Lymphocytes
A) Foreign body response B) Graft-versus-host disease C) Biocompatibility D) Acute inflammation only
A) Contact lenses B) Skin repair devices C) Dental implants D) Joint replacements
A) Only the damaged tissue B) The implant C) No structures are isolated D) Immune cells
A) Starch B) DNA C) Silk D) Cellulose
A) Toxic B) Non-biodegradable C) Inert D) Biodegradable
A) Flexural rigidity B) Young's Modulus C) Tensile strength D) Ductility
A) Cyclic olefin polymer (COP) B) Polyetherimide (PEI) C) Polypropylene (PP) D) Polycarbonate (PC)
A) Suppress the immune response entirely B) Elicit a strong immune reaction C) Avoid any interaction with the immune system D) Direct the immune response rather than circumvent it
A) Elasticity B) Compressive strength C) Toughness D) Flexural rigidity
A) Aluminum B) Ivory C) Stainless steel D) Ceramic
A) X-ray Diffraction B) Nuclear Magnetic Resonance C) Mass Spectrometry D) Scanning Electron Microscopy
A) Line defects B) Point defects C) Macrostructure D) Edge dislocation |